{"name":"Achilles Therapeutics UK Limited","slug":"achilles-therapeutics-uk-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOUXNBbUZoNWZQMTlDdmxWZHd1djNpVm93TWhYSDNrRDRXbWRqZmFGR2ZLSWZ2d1J2a1E1QnJjbkJTc1hqS0NnYlZfbnFETGJDR0Y0VFBKV1h2dEFneW9BTTZGVHpZTkF6dl92Zi1BanZMeUNTNkpPZF9kaFBQT0tpcGRaWDBNeXQ1QUx5MFVJdG9wbFJzZ1hBeGdVbTN1bWFBWHktWTNBU2lRclJUMGxCLVdSZmtOaDIxZWdBMzk0OEo1VUgzTndYNk9xejducXk0TkotZ280ZXRTcy0tX0h2OVhFUTRSbm41ZmZsdEthVmJBOVJFX1E?oc=5","date":"2026-04-02","type":"trial","source":"Barchart.com","summary":"Melanoma Clinical Trial Pipeline Gains Momentum: 150+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Melanoma Clinical Trial Pipeline Gains Momentum: 150+ Companies Lead the Charge in Pioneering New Treatments | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQU1c5QWt0THU4WkNKR0ZuWVA5WXRucG0xdThfbERHelIwazRYYzVXMV9MYmhUTVBOSDhWLWNLZVhSRi1NNXVyOHhiMWJkcHV3SVdaZTlSVDZjT3NJTEduZHMtZDdhVkR6LWNPQWhIRXhSWXdkTmRoUmN5ZzVMLUlqaVAxcjR1cFpXX3RuZG5aVTVKWE1POXc?oc=5","date":"2025-09-01","type":"pipeline","source":"The Lancet","summary":"Establishing the China–UK Cancer Prevention and Control Alliance - The Lancet","headline":"Establishing the China–UK Cancer Prevention and Control Alliance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"endpoints.news","summary":"IPO Tracker (2021) - endpoints.news","headline":"IPO Tracker (2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOM1lHWnlETkg5OGVOdHFBbzlZZEMyNWlfYmQ1b09XMGJtZV94dnREWVNPQVA0a2V5d2lWYkRVb19vZFF0YU5KU3A3Um85bnVrY2hqRjg3WVJyRW5TVTl2RDFLMW5sOGMtNEFsVXBoLUFtY3k0Z1JXcUdKUnhqUER3WTdVV0xCTGhJcWNxMFlVYnZHNlgtcFdKc3Vadk5GcEU2dE80enktTE9BMklUbFFWTkRORHZFSVBISDdVclBwRkFMeDUwNUN6VA?oc=5","date":"2025-01-31","type":"pipeline","source":"Pharmaceutical Technology","summary":"Rentschler closes UK cell and gene therapy facility and does a pivot to biologics - Pharmaceutical Technology","headline":"Rentschler closes UK cell and gene therapy facility and does a pivot to biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOZmQ3TFktemF3YnFDM3lYZ09XeFNPWmNtNGxfUzgtODJmSE80Yno4S3dkQTdkbWdSanJ6YTRYVXJqeVRQckZEQkIxSUZpVVpOT3J2Vy1zUTVwaHNCcERpdV9oZUR0Vy10eV9Ja0NfRjVGOFRzMkhlRXdqa0E3MEJsNzMyOWZ4ZGJRdVBUaHczUjI1Yzl2ZDJJV0E0bFhvV0Yyd3kyTHJEcmx1VnVSZmcyMUE0NjVUU1N4MTlfb2MzelRKVkRqWjRuSWVzZk9zWFR0WUcyVjgzZDQzRExq?oc=5","date":"2024-12-24","type":"pipeline","source":"GlobeNewswire","summary":"Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca - GlobeNewswire","headline":"Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPT2ppUjRYZ2xHMFFtajRaM2V5bXRac3FjZ2xiLXU4SzlwalBJMHJQYVdmYlEtWmo2TWNxaFhZSm4tRklWcFpnS28weUYwaGd4RWgzcGE2czBNR0pYNGRKTklkN2hnUC1jR25KSzMtTEU0ZTRlNG5sNVBaWDRzdFVrWFdSU1pJdw?oc=5","date":"2024-09-20","type":"pipeline","source":"pharmaphorum","summary":"Job losses loom at Achilles as TIL therapy platform is cut - pharmaphorum","headline":"Job losses loom at Achilles as TIL therapy platform is cut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQSzhLaDNOV1lyamNOeEx4MW1vME5BdjUyNHAyeWhraHJwQW55bDdjeWNBUE94Wmw1a3hrQUwyQUdwc210dTU2YTNlNTVRWG5sVGo0SjZDTUxoczhsRW1rdi0tS1RxcVZPTGRpaV9lV2M5LTlNX2FRR3BkLXlJMTdqOVE5U1h3LWhUWUdQYThvNjI0S19NTmFqNll0dkZCTFhSbTE0MzRnaERLVU5jVVRlMDBJNUhoQl9MUjB6MmR0dHZjVnlaQ2c?oc=5","date":"2024-09-19","type":"pipeline","source":"Fierce Biotech","summary":"Achilles drops cell therapy program, braces for layoffs after missing 'commercial viability' goals - Fierce Biotech","headline":"Achilles drops cell therapy program, braces for layoffs after missing 'commercial viability' goals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPUW40U1EtOGhJa0pBVl9XVFIwZktuYlMyb2hDNXEzelNCZkZvWmVlZTVqal9xM3RLc0FxYTNfMDJkem42cnc4QXNwZS0zbHoxNXhvUTU0RmIwYmZRR0tUalk0dFA0cWdpVXhleE42a1J4QUNmejh4eFBYV1NiVDIwNF90dzh1clphVFB2TGVfWQ?oc=5","date":"2021-04-08","type":"pipeline","source":"pharmaphorum","summary":"Cancer Research UK spinout Achilles raises $175.5m in IPO - pharmaphorum","headline":"Cancer Research UK spinout Achilles raises $175.5m in IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQUzJweW5tbmIzR0gweVh0Zjktajd1Mm9zSjZwQ1VicHdzNExhZEhDTTFJX2ZyNDRQWlE1NUtIZG1lU0M4dmlkYkVPZjJ5U2ZXMmpUeExETGFWekoxZHZNZ3Ffb0Rzc2oweFdIcW9CMDZybDd0TVFFTkhveG1kOHowNkFYODM1RWdPSlc5Y0VwYjZhc0lPSjZiTm5VQTdFbGlxTk5ORXNfd284YmVQaFFtYVlpM2tHMDMweF9heG9iM2QxSk1fbVJ5amJTcFhUbnQxdjZEVWxCMXc0QQ?oc=5","date":"2016-10-05","type":"pipeline","source":"Cancer Research UK - Cancer News","summary":"Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer - Cancer Research UK - Cancer News","headline":"Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer - Cancer Research UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOLU1sMlJQdVRHSWJGS3VIazlPNEg3TDNyaHZHaHplZV9sNER4WlluZVZXLUVCaUNGZklsRVd5OHZ5dW5Wa0hOcGg2LW9NblZ1NFp0YWtvZmJfUHBpWU9vMFZWRHhTQ0dKeXZoMl9Kby1Sd1JoYTV0QWNkbk9BU1prSXhKX2JnanVNUDlRT1gxOGpabnJMSTlYaXNZcUZkZw?oc=5","date":"2016-10-05","type":"pipeline","source":"BioSpace","summary":"Syncona, Cancer Research Technology Launch Achilles With $17.5 Million - BioSpace","headline":"Syncona, Cancer Research Technology Launch Achilles With $17.5 Million","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}